The Prostate

Cover image for Vol. 73 Issue 3

15 February 2013

Volume 73, Issue 3

Pages 227–336

  1. Original Articles

    1. Top of page
    2. Original Articles
    3. Errata
    1. Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy (pages 227–235)

      Sisto Perdonà, Dario Bruzzese, Matteo Ferro, Riccardo Autorino, Ada Marino, Claudia Mazzarella, Giuseppe Perruolo, Michele Longo, Rosa Spinelli, Giuseppe Di Lorenzo, Andrea Oliva, Marco De Sio, Rocco Damiano, Vincenzo Altieri and Daniela Terracciano

      Version of Record online: 20 JUL 2012 | DOI: 10.1002/pros.22561

    2. Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer (pages 236–241)

      Noel J. Whitaker, Wendy K. Glenn, Arisha Sahrudin, Matthew M. Orde, Warick Delprado and James S. Lawson

      Version of Record online: 31 JUL 2012 | DOI: 10.1002/pros.22562

    3. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer (pages 242–249)

      Jean-Nicolas Cornu, Géraldine Cancel-Tassin, Christophe Egrot, Cécile Gaffory, François Haab and Olivier Cussenot

      Version of Record online: 20 JUL 2012 | DOI: 10.1002/pros.22563

    4. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy (pages 250–260)

      Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén and Lise Lund Håheim

      Version of Record online: 20 JUL 2012 | DOI: 10.1002/pros.22564

    5. Serum zinc and prostate cancer risk in a nested case–control study: The multiethnic cohort (pages 261–266)

      Song-Yi Park, Lynne R. Wilkens, J. Steven Morris, Brian E. Henderson and Laurence N. Kolonel

      Version of Record online: 31 JUL 2012 | DOI: 10.1002/pros.22565

    6. The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way (pages 267–277)

      Sanjay N. Mediwala, Huiying Sun, Adam T. Szafran, Sean M. Hartig, Guru Sonpavde, Teresa G. Hayes, Perumal Thiagarajan, Michael A. Mancini and Marco Marcelli

      Version of Record online: 20 JUL 2012 | DOI: 10.1002/pros.22566

    7. Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury (pages 278–286)

      Dalsan You, Myoung Jin Jang, Jiyeon Lee, Nayoung Suh, In Gab Jeong, Dong Wan Sohn, Sae Woong Kim, Tai Young Ahn and Choung-Soo Kim

      Version of Record online: 20 JUL 2012 | DOI: 10.1002/pros.22567

    8. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades (pages 296–305)

      Seong Won Kim, Sung-Moo Kim, Hang Bae, Dongwoo Nam, Jun-Hee Lee, Seok-Geun Lee, Bum Sang Shim, Sung-Hoon Kim, Kyoo Seok Ahn, Seung-Hoon Choi, Gautam Sethi and Kwang Seok Ahn

      Version of Record online: 9 AUG 2012 | DOI: 10.1002/pros.22574

    9. Anterior gradient 2 (AGR2): Blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype (pages 306–315)

      Kian Kani, Paymaneh D. Malihi, Yuqiu Jiang, Haiying Wang, Yixin Wang, Daniel L. Ruderman, David B. Agus, Parag Mallick and Mitchell E. Gross

      Version of Record online: 21 AUG 2012 | DOI: 10.1002/pros.22569

    10. Prostate epithelial AR inactivation leads to increased intraprostatic androgen synthesis (pages 316–327)

      Keely M. McNamara, Yasuhiro Nakamura, Hironobu Sasano, David J. Handelsman and Ulla Simanainen

      Version of Record online: 13 SEP 2012 | DOI: 10.1002/pros.22570

    11. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer (pages 328–335)

      Amit M. Algotar, M. Suzanne Stratton, Frederick. R. Ahmann, James Ranger-Moore, Raymond B. Nagle, Patricia A. Thompson, Elizabeth Slate, Chiu H. Hsu, Bruce L. Dalkin, Puneet Sindhwani, Michael A. Holmes, John A. Tuckey, David. L. Graham, Howard L. Parnes, Lawrence C. Clark and Steven P. Stratton

      Version of Record online: 10 AUG 2012 | DOI: 10.1002/pros.22573

  2. Errata

    1. Top of page
    2. Original Articles
    3. Errata
    1. You have free access to this content
      Erratum: Anti-angiogenic effects and mechanism of prazosin (page 336)

      Chun-Hou Liao, Jih-Hwa Guh, Shih-Chieh Chueh and Hong-Jeng Yu

      Version of Record online: 21 JUN 2012 | DOI: 10.1002/pros.22555

      This article corrects:

      Anti-angiogenic effects and mechanism of prazosin

      Vol. 71, Issue 9, 976–984, Version of Record online: 6 DEC 2010